Tianjin Chase Sun Pharmaceutical Co.,Ltd.’s Net Profit Rose 0.1% in First Half of 2023

Tianjin Chase Sun Pharmaceutical Co.,Ltd. (天津红日药业股份有限公司) (300026.SZ) reported a net profit of 349.7 million yuan in the first half of 2023, up 0.1% year-on-year.

Meanwhile, the company posted 3.4 billion yuan in revenue, up 3.4% year-on-year.

At the end of the reporting period, it had 12.4 billion yuan in total assets and 3.7 billion yuan in total liabilities, with a liability-to-asset ratio of 29.9%.